Solving COVID: November 4, 2020
Pre-flight COVID testing, new research on immunity, and more
- 1. United Airlines offers free pre-flight coronavirus testing on some routes
- 2. New coronavirus study suggests T-cell immunity may last for at least 6 months
- 3. Slovakia tests two-thirds of its population
- 4. CureVac says vaccine candidate triggered immune response
- 5. AI can spot COVID-19 cases based on how people 'produce sound,' researchers find
1. United Airlines offers free pre-flight coronavirus testing on some routes
United Airlines is trying out a plan to offer free COVID-19 tests to passengers heading abroad. From Nov. 16 to Dec. 11, United will offer rapid coronavirus tests to people boarding certain flights from the airline's Newark, New Jersey, hub to London's Heathrow airport. The Abbott ID Now rapid tests will be available for Monday, Wednesday, and Friday flights. Passengers who refuse a test will be moved to other flights to "guarantee that essentially everyone on board just tested negative for COVID-19." Still, travelers arriving in the U.K. will have to quarantine for 14 days when they arrive. The COVID-19 pandemic has decimated the airline industry, and without a government intervention, airlines are trying whatever they can to get passengers back on board.
2. New coronavirus study suggests T-cell immunity may last for at least 6 months
T-cell immunity against the coronavirus could last for at least six months after infection, a study from the U.K. Coronavirus Immunology Consortium suggests. The study, which is awaiting peer review, evaluated 100 health-care workers in the U.K. who had mild or asymptomatic COVID-19 cases in March and April and found that the defensive blood cells, which differ from antibodies, were present in all of them. The patients who experienced symptoms had T-cell levels that were at least 50 percent higher than the asymptomatic cases. The results are promising, especially given that other recent studies have suggested antibodies are waning among the general population, but not definitive. Fiona Watt, the executive chair of the U.K.'s Medical Research Council, was optimistic. "If natural reinfection with the virus can elicit a robust T-cell response, then this may mean that a vaccine could do the same," she said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
3. Slovakia tests two-thirds of its population
Slovakia tested two-thirds of its population for COVID-19 over the weekend. More than 40,000 medical workers, army personnel, and police were deployed to collect samples at around 5,000 testing sites. The effort utilized antigen tests, which give quick results, but are often less accurate than PCR tests, which require lab analysis. Just over 1 percent of the 3.6 million participants tested positive. The ambitious plan was not without its critics. While Prime Minister Igor Matovic said it would save "hundreds of lives" and "will be our road to freedom," President Zuzana Caputova called it "unfeasible," noting that there are not enough trained health workers to carry it out effectively. And the Slovak Association of General Practitioners warned that the "mass concentration of millions of people" at testing sites could in fact contribute to the coronavirus' spread. Participation was voluntary, but those who opted out will have to comply with more severe restrictions.
4. CureVac says vaccine candidate triggered immune response
CureVac said on Monday that its coronavirus vaccine candidate triggered an immune response during a phase 1 trial. "We are very encouraged by the interim Phase 1 data," CureVac CEO Franz-Werner Haas said. The company in a statement said that during the study, its vaccine candidate "was generally well tolerated across all tested doses," and it "induced strong binding and neutralizing antibody responses." CureVac said it will provide detailed data in "the coming weeks," but its chief technology officer, Mariola Fotin-Mleczek, said the initial data shows "a robust and highly efficient immune response." The company is planning to begin the final stage of testing for its vaccine candidate before the end of 2020.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
5. AI can spot COVID-19 cases based on how people 'produce sound,' researchers find
Researchers at the Massachusetts Institute of Technology have published a paper suggesting artificial intelligence can recognize potential coronavirus cases based on how people sound — particularly how they sound when they produce a "forced-cough." The MIT team employed an AI model that was able to accurately identify 98.5 percent of people who were confirmed to have been infected by the coronavirus. The accuracy actually ticked up to 100 percent among people who were not displaying symptoms. "We think this shows that the way you produce sound changes when you have COVID, even if you're asymptomatic," Brian Subirana, the paper's co-author told PCMag. Now, researchers are working to build an app that uses the AI model. In theory, that could serve as a free, non-invasive way to pre-screen for COVID-19, though it would not itself be a diagnostic tool.
Create an account with the same email registered to your subscription to unlock access.
-
Why is Tesla stumbling?
In the Spotlight More competition, confusion about the future and a giant pay package for Elon Musk
By Joel Mathis, The Week US Published
-
How Taylor Swift changed copyright negotiations in music
under the radar The success of Taylor's Version rerecordings has put new pressure on record labels
By Theara Coleman, The Week US Published
-
Job scams are increasingly common. Here's what to look out for.
The Explainer You should never pay for an application or give out your personal info before being hired
By Becca Stanek, The Week US Published
-
Nigeria's worsening rate of maternal mortality
Under the radar Economic crisis is making hospitals unaffordable, with women increasingly not receiving the care they need
By Harriet Marsden, The Week UK Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
How happy is Finland really?
Today's Big Question Nordic nation tops global happiness survey for seventh year in a row with 'focus on contentment over joy'
By Harriet Marsden, The Week UK Published
-
How Tehran became the world's nose job capital
Under the radar Iranian doctors raise alarm over low costs, weak regulation and online influence of 'Western beauty standards'
By Harriet Marsden, The Week UK Published
-
Africa's renewed battle against female genital mutilation
Under the radar Campaigners call for ban in Sierra Leone after deaths of three girls as coast-to-coast convoy prepares to depart
By Harriet Marsden, The Week UK Published
-
Argentina: the therapy capital of the world
Under the radar Buenos Aires natives go hungry to pay for psychoanalysis, amid growing instability, anxiety – and societal acceptance
By Harriet Marsden, The Week UK Published
-
Does declining birth rate spell doom for Britain?
Today's Big Question Ageing population puts pressure on welfare state, economy and fabric of society, while fertility is rising on populist agendas
By Harriet Marsden, The Week UK Published
-
How a new blood test could revolutionise sepsis diagnosis
The Explainer Early results from ongoing trial suggest faster identification of deadly condition is possible
By The Week Staff Published